Today's Date
Targeting IL-7Rα in Vitiligo
(
)
ITN Protocol #:
ITN103AI
Branded Name:
Treatment Protocol #:
Therapeutic Area:
Autoimmune Disease
Current Status:
Development
Summary:
Targeting the Interleukin-7 Receptor Alpha Chain in Non-Segmental Vitiligo: A Phase 2a Double-Blind Placebo Controlled Multicenter Trial of ZB-168
Clinical Operations Manager
ITN Biologist
Study Personnel:
